Investors / Israel / RAD BioMed Accelerator
RAD BioMed Accelerator
Venture capital · Israel · Middle East and Africa
RAD BioMed is the investment arm of the RAD Bynet group, making hands-on early-stage investments in ventures based in Israel. It builds on the group's MedTech and HiTech experience and has expanded its focus to Health, Technology, and Energy sectors.
Invests inHealthcare & Biotech
In its own wordsmedtechhealthtechenergydeep techisrael
Your fit with RAD BioMed Accelerator
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsRAD BioMed Accelerator lists 10 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (73%), Fintech (9%) and Mobility & Logistics (9%). 71% of its companies are based in Israel. It invests most often alongside Champel Capital, Pix Vine Capital and BioLight Life Sciences.
No funding round on record names RAD BioMed Accelerator yet, so the figures come from its portfolio page.
Round figures show recent activity, not RAD BioMed Accelerator's whole history. Rounds on record name 0 companies; its own site lists 10. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 23th | 10 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 92th | 73% in its largest sector |
| Reach | 42th | 2 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers990%
- No longer answers00%
- Points to another company110%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 73% | 15% |
| Fintech | 9% | 12% |
| Mobility & Logistics | 9% | 1% |
| Industrial & Manufacturing | 9% | 7% |
Co-investor network
who it backs companies with, and who they back togetherCompare RAD BioMed Accelerator head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
10 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
Healthcare & Biotech | Portfolio page | |||
| Everads Therapy is developing treatments for retinal diseases using novel delivery technology via the suprachoroidal delivery route. | Healthcare & Biotech | Portfolio page | ||
| Moebius Medical is a clinical-stage biotech company developing treatments for osteoarthritis | Healthcare & Biotech | Portfolio page | ||
| Perflow is a company mentioned in the portfolio of RAD Biomed | Healthcare & Biotech | Portfolio page | ||
| Radiaction Medical has developed a system to proactively block radiation at the source, providing the interventional team with comprehensive scatter radiation protection | Healthcare & Biotech | Portfolio page | ||
| REE develops and provides electric vehicle platforms and technology for commercial fleet vehicle electrification | Mobility & LogisticsIndustrial & Manufacturing | Portfolio page | ||
| SynVaccine specializes in viral engineering for the development of potent vaccines, viral-based gene therapy and cancer immunotherapy. | Healthcare & Biotech | Portfolio page | ||
| Laminate designs, manufactures, and fulfills physical debit and credit cards for issuers. | Fintech | Portfolio page | ||
| Vectorious develops and implements implantable sensors for heart failure management | Healthcare & Biotech | Portfolio page | ||
| Zsquare develops and markets single-use endoscopes for medical use | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- radbiomed.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 10
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get RAD BioMed Accelerator's profile as data
Pull RAD BioMed Accelerator's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/radbiomed.com
# also
GET /v1/firms/radbiomed.com/portfolio
GET /v1/firms/radbiomed.com/coinvestors
GET /v1/firms/radbiomed.com/news